Lorlatinib for the Treatment of ALK Fusion–Positive Infant-Type Hemispheric Glioma: A Case Report-Reference-Cited by-同舟云学术

Lorlatinib for the Treatment of ALK Fusion–Positive Infant-Type Hemispheric Glioma: A Case Report

Published:2022-10 Issue:6 Volume: Page:
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precision Oncology

Author:

Greenwell Alyssa M.¹^ORCID,Baughan Scott²^ORCID,Altinok Deniz³,Marupudi Neena I.⁴^ORCID,Kupsky William⁵,Kumar-Sinha Chandan⁶^ORCID,Gorsi Hamza S.⁷^ORCID

Affiliation:

1. Children's Hospital of Michigan, Detroit, MI

2. Wayne State University School of Medicine, Detroit, MI

3. Department of Radiology, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI

4. Department of Pediatric Neurosurgery, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI

5. Department of Pathology, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI

6. Department of Pathology, Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI

7. Department of Hematology/Oncology, Children's Hospital of Michigan, Central Michigan University School of Medicine, Mount Pleasant, MI

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.22.00255

Reference25 articles.

1. Novel PPP1CB-ALK fusion protein in a high-grade glioma of infancy

2. Lorlatinib in a Child with ALK-Fusion–Positive High-Grade Glioma

3. Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes

4. Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas

5. Infantile/Congenital High-Grade Gliomas: Molecular Features and Therapeutic Perspectives

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multi-institutional series of a novel, recurrent TRIM24::MET fusion-driven infant-type hemispheric glioma reveals significant clinico-pathological heterogeneity;Acta Neuropathologica Communications;2024-06-21

2. An Infant-Type Hemispheric Glioma With SOX5::ALK: A Novel Fusion;Journal of the National Comprehensive Cancer Network;2024-02

3. Case report: ATIC-ALK fusion in infant-type hemispheric glioma and response to lorlatinib;Frontiers in Oncology;2023-02-24